Pharmabiz15h
AI and digital tech reshape a new era in drug discovery and career avenues: Dr. Kunal Gokhale
AI and digital tech reshape a new era in drug discovery and career avenues: Dr. Kunal Gokhale: Shardul Nautiyal, Mumbai ...
Pharmabiz7h
BioArctic’s partner Eisai launches Leqembi in South Korea to treat MCI due to AD or mild AD dementia
BioArctic’s partner Eisai launches Leqembi in South Korea to treat MCI due to AD or mild AD dementia: Stockholm, Sweden Friday, November 29, 2024, 16:00 Hrs [IST] BioArctic ABs ...
Pharmabiz12h
European Commission approves GSK’s fully liquid Menveo meningococcal vaccine
European Commission approves GSK’s fully liquid Menveo meningococcal vaccine: London, UK Friday, November 29, 2024, 11:00 Hrs [IST] GSK plc announced that the European Commissio ...
Pharmabiz10h
UK MHRA approves new diagnostic agent, flortaucipir for adult patients showing signs of cognitive impairment for Alzheimer’s disease
UK MHRA approves new diagnostic agent, flortaucipir for adult patients showing signs of cognitive impairment for Alzheimer’s disease: United Kingdom Friday, November 29, 2024, 1 ...
Pharmabiz15h
DoP rejects review application of Cipla against price fixation of antiviral drug acyclovir 800 mg
DoP rejects review application of Cipla against price fixation of antiviral drug acyclovir 800 mg: Gireesh Babu, New Delhi Friday, November 29, 2024, 08:00 Hrs [IST] The Departmen ...
Pharmabiz8h
Innovent announces first-time inclusion of Sintbilo and new indication for olverembatinib in China’s National Reimbursement Drug List
Innovent announces first-time inclusion of Sintbilo and new indication for olverembatinib in China’s National Reimbursement Drug List: San Francisco, US Friday, November 29, 202 ...
Pharmabiz8h
CureSMA Foundation of India lauds government and judiciary for historic Rs. 900+ crore allocation to rare disease treatment
CureSMA Foundation of India lauds government and judiciary for historic Rs. 900+ crore allocation to rare disease treatment: Our Bureau, Mumbai Friday, November 29, 2024, 14:30 Hr ...
Pharmabiz13h
China’s NRDL includes Akeso’s two bispecific antibody drugs, cadonilimab & ivonescimab
China’s NRDL includes Akeso’s two bispecific antibody drugs, cadonilimab & ivonescimab: Hong Kong Friday, November 29, 2024, 10:00 Hrs [IST] Akeso, Inc., a leading biopharmace ...
Pharmabiz11h
Lin BioScience’s LBS-007 gets US FDA Fast Track Designation to treat acute myeloid leukaemia and acute lymphocytic leukaemia
Lin BioScience’s LBS-007 gets US FDA Fast Track Designation to treat acute myeloid leukaemia and acute lymphocytic leukaemia: Taipei City, Taiwan Friday, November 29, 2024, 12:0 ...
Pharmabiz9h
CDSCO declares 60 drug samples tested in October as NSQ, three as spurious
CDSCO declares 60 drug samples tested in October as NSQ, three as spurious: Our Bureau, New Delhi Friday, November 29, 2024, 13:30 Hrs [IST] The Central Drugs Standard Control Org ...
Pharmabiz10h
Pfizer India and the State of Goa launch ‘Project Parivartan’ to tackle AMR and strengthen infection control
Pfizer India and the State of Goa launch ‘Project Parivartan’ to tackle AMR and strengthen infection control: Our Bureau, Bengaluru Friday, November 29, 2024, 12:15 Hrs [IST] ...
Pharmabiz11h
Lupin receives US FDA tentative approval for generic Janumet tablets
Lupin receives US FDA tentative approval for generic Janumet tablets: Our Bureau, Mumbai Friday, November 29, 2024, 11:15 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...